Results 141 to 150 of about 136,777 (328)
Ankylosing Spondylitis and Prolonged ACTH Therapy [PDF]
H. F. West, G.R. Newns
openalex +1 more source
Progress in our understanding of the pathogenesis of ankylosing spondylitis
AS is a common rheumatic condition characterized by inflammation and new bone formation. The pathogenesis of AS is likely multifactorial and has not been fully elucidated to date. A major genetic role has been demonstrated.
D. Simone+2 more
semanticscholar +1 more source
ABSTRACT Background Bimekizumab, a monoclonal antibody targeting interleukin (IL)‐17A and IL‐17F, has shown efficacy in psoriatic arthritis (PsA) clinical trials, but real‐world data on its effectiveness are limited. This study aimed to evaluate its real‐world effectiveness in PsA patients treated in dermatologic settings.
Giacomo Caldarola+12 more
wiley +1 more source
Quality of life in patients with Ankylosing Spondylitis in Duhok government, Kurdistan of Iraq
Background and objectives: Spondylarthritis is a broad spectrum of chronic inflammatory diseases, and one of its of phenotypes is ankylosing spondylitis.
Nahida Zuber Ali+1 more
doaj +1 more source
Disseminated Tuberculosis Mimicking Ankylosing Spondylitis
Ankylosing spondylitis is a chronic inflammatory disorder affecting mainly the axial skeleton. Here we report a case of a man with a clinical suspicion of ankylosing spondylitis but with a persistence of increased inflammatory markers.
Valérie Huyge+2 more
doaj +1 more source
Role of subclinical gut inflammation in the pathogenesis of spondyloarthritis [PDF]
Subclinical gut inflammation occurring in patients affected by spondyloarthritis (SpA) is correlated with the severity of spine inflammation. Several evidences indicate that dysbiosis occurs in SpA, and that may modulate intestinal permeability and ...
Ciccia F.+3 more
core +1 more source
European Guideline (EuroGuiDerm) on atopic eczema: Living update
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg+31 more
wiley +1 more source
Frequency of inflammatory back pain and sacroiliitis in Egyptian patients with rheumatoid arthritis
Background The aim of this study is to determine the frequency of inflammatory back pain and associated ankylosing spondylitis in rheumatoid arthritis patients. Results Sacroiliitis was found in 22% of rheumatoid arthritis patients.
N.M.M. Osman+4 more
doaj +1 more source
Emerging patterns of genetic overlap across autoimmune disorders. [PDF]
Most of the recently identified autoimmunity loci are shared among multiple autoimmune diseases. The pattern of genetic association with autoimmune phenotypes varies, suggesting that certain subgroups of autoimmune diseases are likely to share ...
Criswell, Lindsey A+1 more
core +1 more source